Tevogen Bio Holdings Inc. - TVGN Net Assets per Single Share
Tevogen Bio Holdings (TVGN) is developing oncology and viral treatments through partnerships with leading laboratories. The business relies on a narrow T-cell therapy profile, creating a significant dependency on primary test results. A lack of profitability and uncertainty surrounding clinical phases leave the company vulnerable to volatility, with the indicator standing at -4.14. This daily price chart for TVGN clearly demonstrates the market dynamics of this asset.
tevogen.com - analytical breakdowns and key metrics (TVGN)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Tevogen Bio Holdings, Inc., TVGN
Investors are assessing the resilience of Tevogen Bio Holdings (TVGN) through the lens of net equity, which, after deducting all liabilities, is allocated per share to reflect the actual value of assets. Analyzing the book value per share allows for a comparison between T-cell therapy development costs and the actual business value, revealing the stock's undervaluation during market downturns.
Competitor analysis
Book Value per Share BIIB|NBIX: Book Value of One Share|Net Assets per Single Share Regencell Bioscience|AXSM (axsome.com) - Equity per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Net Asset Value per Share Trevi Corp|Praxis Precision Medicines (PRAX) - Accounting Value per Share|Book Price of a Share anavex.com|CeriBell - Book Value per Share|Net Asset Value per Share Prothena Corporation PRTA|Accounting Value per Share Alector ALEC|Annexon Biosciences Inc. - Net Assets per Single Share|OMER (Omeros Corp.) - Net Assets per Single Share|NGNE - Net Asset Value per Share|Book Value per Share ACIU (AC Immune SA)|Voyager Therapeutics Inc (VYGR) - Book Value of One Share|Book Value per Share NMRA (Neumora Therapeutics Inc)|Net Asset Value per Share SCLX|Net Assets per Single Share Alpha Cognition ACOG|Equity per Share Cognition Therapeutics Inc. CGTX|Accounting Value per Share Inhibikase Therapeutics, Inc.|Accounting Value of a Share Cassava Sciences Inc SAVA|ASRT - Book Value per Share|COYA - Net Assets per Single Share|vistagen.com - Book Value per Share|OVID (Ovid Therapeutics) - Net Assets per Share|Net Assets per Single Share ABOS (Acumen Pharmaceuticals, Inc.)|Net Asset Value per Share CervoMed, Inc. (CRVO)|Alterity Therapeutics (ATHE) - Accounting Value per Share|Accounting Value of a Share clene.com (CLNN)|Book Value per Share PepGen|Jupiter Neurosciences, Inc. - Accounting Value of a Share|RLMD (Relmada Therapeutics, Inc.) - Net Assets per Single Share|ANVS: Net Asset Value per Share|gracetx.com (GRCE) - Net Assets per Single Share|Firefly Neuro (AIFF) - Net Assets per Single Share|Book Value per Share ANEW Medical (KLTO)|Equity per Share NeuroSense Therapeutics, Ltd.|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Book Value per Share|Net Assets per Share MTVA (metaviatx.com)|NRXS - Net Assets per Single Share|Equity per Share Helius Medical Technologies, Inc. HSDT|Book Value per Share PASG|NEUP: Book Value of One Share|Minerva Neurosciences, Inc. - Net Assets per Single Share|Net Assets per Share Athira Pharma Inc|Addex Therapeutics, Ltd. (ADXN) - Accounting Value per Share|Book Price of a Share Alzamend (ALZN)|Accounting Value per Share Cyclerion Therapeutics (CYCN)|Net Assets per Single Share protagenic.com (PTIX)|KTTA (Pasithea Therapeutics Corp.) - Book Value per Share|Cortigent Inc - Book Value of One Share|Avenue Therapeutics, Inc (ATXI) - Net Assets per Single Share|BCLI: Equity per Share|Net Assets per Single Share Cara Therapeutics, Inc.|chromocell.com (CHRO) - Equity per Share|Book Value per Share ELYM (Eliem Therapeutics, Inc.)|Net Asset Value per Share Intra-Cellular (ITCI)|Accounting Value per Share LBPH|Book Value per Share MRNS (Marinus Pharma)|Net Assets per Single Share NKGen Biotech, Inc.|neurobopharma.com - Accounting Value of a Share|SAGE (Sage Therapeutics) - Net Assets per Single Share|Synaptogenix Inc. (SNPX) - Net Asset Value per Share|TRVN - Accounting Value per Share|Vigil Neuroscience, Inc. (VIGL) - Book Price of a Share|Book Value per Share WENA (Anew Medical)|Net Asset Value per Share cerevel.com (CERE)